Buy this article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.



August 2004, Volume 34 Number 8 , p 30 - 30




  • Source

    Licofelone, an experimental analgesic, causes less gastrointestinal (GI) adverse reactions than naproxen, according to a study involving healthy volunteers. Both are considered to be nonsteroidal anti-inflammatory drugs (NSAIDs), a group of drugs known for the potential to cause GI problems.

    Researchers randomly assigned 121 volunteers to one of four groups. The volunteers took twice-daily doses of licofelone (200 mg or 400 mg), naproxen (500 mg), or a placebo. After 4 weeks, they underwent endoscopy. Twenty percent of those who took naproxen twice daily for 4 weeks developed stomach ulcers. No one in the groups taking licofelone or placebo developed an ulcer.

    Licofelone is an inhibitor of both cyclooxygenase-1 (COX-1) and COX-2 and an enzyme called 5-lipoxygenase (5-LOX); consequently, it's categorized as a LOX-COX inhibitor. Naproxen is a non-selective COX inhibitor.

    Other research has shown that licofelone, like conventional ...

To continue reading, buy this article for just $3.95.

Have a coupon or promotional code? Enter it here: